18 Facts About Sun Pharma

1. Sun Pharma had forayed into the Japanese prescription market in 2016 with the acquisition of 14 established prescription brands from Novartis.

FactSnippet No. 849,730

2. Sun Pharma had entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded, and generic products in Japan, it said in a regulatory filing dated 26 November 2018.

FactSnippet No. 849,729

3. Sun Pharma acquires a basket of products from Natco Pharma.

FactSnippet No. 849,728

4. Sun Pharma commissions first joint venture manufacturing unit in Dhaka, Bangladesh.

FactSnippet No. 849,727

5. Sun Pharma sets up new formulation unit in Jammu, India.

FactSnippet No. 849,726

6. Sun Pharma begins operations at a new formulation unit in Silvassa, Gujarat, India.

FactSnippet No. 849,725

7. Sun Pharma sets up compact manufacturing facility for tablets and capsules at Vapi, Gujarat.

FactSnippet No. 849,722

8. Sun Pharma acquires Biosintez to enhance presence in Russian market.

FactSnippet No. 849,721

9. Sun Pharma acquires branded oncology product Odomzo® from Novartis for global markets.

FactSnippet No. 849,720

10. Sun Pharma acquires Ocular Technologies, Sarl to strengthen branded ophthalmic portfolio.

FactSnippet No. 849,719

11. Sun Pharma acquires Ranbaxy in a US$ 4 billion landmark transaction to create world's fifth largest specialty generic pharma company.

FactSnippet No. 849,717

12. Sun Pharma completes buyout of manufacturing unit in Bryan, Ohio, US.

FactSnippet No. 849,712

13. Sun Pharma established with five psychiatry products and a two person marketing team.

FactSnippet No. 849,707

14. In 1998, Sun Pharma acquired a number of respiratory brands from Natco Pharma.

FactSnippet No. 849,702 - en.wikipedia.org

15. Sun Pharma stood second in the India's Most Reputed Brands list in a study conducted by BlueBytes, a leading Media Analytics firm in association with TRA Research, a brand insights organization (both a part of the Comniscient Group).

FactSnippet No. 121,904 - en.wikipedia.org

16. In March 2015, Sun Pharma announced it had agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

FactSnippet No. 121,903 - en.wikipedia.org

17. In 2011, Sun Pharma entered into a joint venture with MSD to bring complex or differentiated generics to emerging markets.

FactSnippet No. 121,902 - en.wikipedia.org

18. Sun Pharma has complemented growth with select acquisitions over the last two decades.

FactSnippet No. 121,901 - en.wikipedia.org